Literature DB >> 19008875

Efficient derivation of functional dopaminergic neurons from human embryonic stem cells on a large scale.

Myung-Soo Cho1, Dong-Youn Hwang, Dong-Wook Kim.   

Abstract

Cell-replacement therapy using human embryonic stem cells (hESCs) holds great promise in treating Parkinson's disease. We have recently reported a highly efficient method to generate functional dopaminergic (DA) neurons from hESCs. Our method includes a unique step, the formation of spherical neural masses (SNMs), and offers the highest yield of DA neurons ever achieved so far. In this report, we describe our method step by step, covering not only how to differentiate hESCs into DA neurons at a high yield, but also how to amplify, freeze and thaw the SNMs, which are the key structures that make our protocol unique and advantageous. Although the whole process of generation of DA neurons from hESCs takes about 2 months, only 14 d are needed to derive DA neurons from the SNMs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19008875     DOI: 10.1038/nprot.2008.188

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  38 in total

1.  Dopaminergic neuronal conversion from adult rat skeletal muscle-derived stem cells in vitro.

Authors:  Jian Yang; Xuan Wang; Yue Wang; Zi-Xuan Guo; Ding-Zhen Luo; Jun Jia; Xiao-Min Wang
Journal:  Neurochem Res       Date:  2012-06-22       Impact factor: 3.996

Review 2.  The iPS technique provides hope for Parkinson's disease treatment.

Authors:  Liang Xu; Yu-Yan Tan; Jian-Qing Ding; Sheng-Di Chen
Journal:  Stem Cell Rev Rep       Date:  2010-09       Impact factor: 5.739

3.  Modeling neurological diseases using patient-derived induced pluripotent stem cells.

Authors:  Tarja A Juopperi; Hongjun Song; Guo-Li Ming
Journal:  Future Neurol       Date:  2011-05

Review 4.  Stem cells on the brain: modeling neurodevelopmental and neurodegenerative diseases using human induced pluripotent stem cells.

Authors:  Priya Srikanth; Tracy L Young-Pearse
Journal:  J Neurogenet       Date:  2014-03-17       Impact factor: 1.250

5.  Large-scale generation of human iPSC-derived neural stem cells/early neural progenitor cells and their neuronal differentiation.

Authors:  Leonardo D'Aiuto; Yun Zhi; Dhanjit Kumar Das; Madeleine R Wilcox; Jon W Johnson; Lora McClain; Matthew L MacDonald; Roberto Di Maio; Mark E Schurdak; Paolo Piazza; Luigi Viggiano; Robert Sweet; Paul R Kinchington; Ayantika G Bhattacharjee; Robert Yolken; Vishwajit L Nimgaonka; Vishwajit L Nimgaonkar
Journal:  Organogenesis       Date:  2014       Impact factor: 2.500

6.  Effects of short-term exposure to sevoflurane on the survival, proliferation, apoptosis, and differentiation of neural precursor cells derived from human embryonic stem cells.

Authors:  Jin-Woo Park; Mi-Sun Lim; So Yeon Ji; Myung Soo Cho; Seong-Joo Park; Sung-Hee Han; Jin-Hee Kim
Journal:  J Anesth       Date:  2017-09-14       Impact factor: 2.078

7.  Isoflurane decreases proliferation and differentiation, but none of the effects persist in human embryonic stem cell-derived neural progenitor cells.

Authors:  Hye-Min Sohn; Hye Young Kim; Seongjoo Park; Sung-Hee Han; Jin-Hee Kim
Journal:  J Anesth       Date:  2016-11-05       Impact factor: 2.078

8.  Human umbilical vein-derived dopaminergic-like cell transplantation with nerve growth factor ameliorates motor dysfunction in a rat model of Parkinson's disease.

Authors:  Ming Li; Shi-Zhong Zhang; Yan-Wu Guo; Ying-qian Cai; Zhong-jie Yan; Zhihao Zou; Xiao-Dan Jiang; Yi-Quan Ke; Xu-ying He; Zeng-liang Jin; Guo-hui Lu; Dao-qing Su
Journal:  Neurochem Res       Date:  2010-07-24       Impact factor: 3.996

9.  Predicting the functional states of human iPSC-derived neurons with single-cell RNA-seq and electrophysiology.

Authors:  C Bardy; M van den Hurk; B Kakaradov; J A Erwin; B N Jaeger; R V Hernandez; T Eames; A A Paucar; M Gorris; C Marchand; R Jappelli; J Barron; A K Bryant; M Kellogg; R S Lasken; B P F Rutten; H W M Steinbusch; G W Yeo; F H Gage
Journal:  Mol Psychiatry       Date:  2016-10-04       Impact factor: 15.992

Review 10.  Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience.

Authors:  Jerome Mertens; Maria C Marchetto; Cedric Bardy; Fred H Gage
Journal:  Nat Rev Neurosci       Date:  2016-05-19       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.